- Home
- ALVO vs TSLX Comparison
ALVO vs TSLX Comparison
Compare ALVO & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- TSLX
- Stock Information
- Founded
- ALVO 2013
- TSLX 2010
- Country
- ALVO Luxembourg
- TSLX United States
- Employees
- ALVO N/A
- TSLX N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- TSLX Investment Managers
- Sector
- ALVO Health Care
- TSLX Finance
- Exchange
- ALVO Nasdaq
- TSLX Nasdaq
- Market Cap
- ALVO 2.5B
- TSLX 2.3B
- IPO Year
- ALVO N/A
- TSLX 2014
- Fundamental
- Price
- ALVO $8.33
- TSLX $24.61
- Analyst Decision
- ALVO
- TSLX Buy
- Analyst Count
- ALVO 0
- TSLX 9
- Target Price
- ALVO N/A
- TSLX $23.39
- AVG Volume (30 Days)
- ALVO 486.2K
- TSLX 342.0K
- Earning Date
- ALVO 08-13-2025
- TSLX 11-04-2025
- Dividend Yield
- ALVO N/A
- TSLX 8.42%
- EPS Growth
- ALVO N/A
- TSLX N/A
- EPS
- ALVO 0.22
- TSLX 2.01
- Revenue
- ALVO $562,478,000.00
- TSLX $474,291,000.00
- Revenue This Year
- ALVO $33.32
- TSLX N/A
- Revenue Next Year
- ALVO $46.16
- TSLX N/A
- P/E Ratio
- ALVO $37.86
- TSLX $12.26
- Revenue Growth
- ALVO 82.19
- TSLX 0.15
- 52 Week Low
- ALVO $7.35
- TSLX $18.58
- 52 Week High
- ALVO $13.70
- TSLX $25.17
- Technical
- Relative Strength Index (RSI)
- ALVO 48.09
- TSLX 58.98
- Support Level
- ALVO $7.85
- TSLX $24.25
- Resistance Level
- ALVO $8.12
- TSLX $24.56
- Average True Range (ATR)
- ALVO 0.27
- TSLX 0.28
- MACD
- ALVO 0.01
- TSLX 0.05
- Stochastic Oscillator
- ALVO 39.47
- TSLX 82.45
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About TSLX Sixth Street Specialty Lending Inc.
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.